Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Nine Kovsie students awarded NAC bursaries

2015-02-19

The UFS is proud to announce that nine of our Drama and Theatre Arts undergraduate students have been awarded National Arts Council (NAC) bursaries for their studies in 2015.

From the left in the photograph, these students are:

• Mbuyiselo Nqodi (first year)
• Marike Jonker (second year)
• Monique de Klerk (second year)
• Aldine van der Merwe (third year)
• Kado Cloete (third year)
• Rondo Mpiti (third year)
• Magnus McPhail (third year)
• Olivia Wyngaard (third year)
• Marica Laing (second year)

This year the amount awarded for the NAC busaries is R70 000.

Since 2005, the NAC has given bursaries to the UFS for the last 10 years. The amount varies from year to year.

“The number of undergraduate students who benefit varies depending on the amount allocated each year,” said Prof Nico Luwes, Head of the Drama and Theatre Arts Department at the UFS.

“Some years, the NAC prescribes how many students will be awarded a bursary and provides a profile of gender and academic prerequisites. Other years, such as the present one, there is no prescription and the UFS was able to cater for the applications submitted, and the number of students who will benefit, within the amount awarded. Normally, it is divided between successful candidates.”

The criteria according to which NAC bursaries are awarded to students every year include academic merit and, of course, their financial situation.”

“The full information of applicants from the Department of Drama and Theatre Arts is checked by the selection committee – all permanent members of staff in the department. The names are then sent to the NAC for approval.
UFS Finances ensures further that the bursary money is paid into the student’s class fees account. During the year and at the end, I report to the NAC on the progress shown by bursary holders. This, in turn, contributes to the excellent co-operation with the NAC so that the following year’s application is then generally successful,” says Luwes.

Bursary monies cover mainly registration and class fees for some or all modules, depending on the amount awarded.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept